Santhera Pharmaceuticals Holding AG (SPHDF)
USD 9.42
(0.0%)
USD 9.42
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 94.03 Million USD | 239.29% |
| 2022 | -45.65 Million USD | 22.01% |
| 2021 | -37.89 Million USD | -11.46% |
| 2020 | -52.52 Million USD | -2683.85% |
| 2019 | -7.78 Million USD | 96.11% |
| 2018 | -46.27 Million USD | 0.07% |
| 2017 | -45.2 Million USD | -63.72% |
| 2016 | -29.63 Million USD | -34.62% |
| 2015 | 4.05 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -8.33 Million USD | -0.4% |
| 2024 Q1 | -8.29 Million USD | -107.53% |
| 2023 Q2 | -20.68 Million USD | -104.75% |
| 2023 FY | - USD | 239.29% |
| 2023 Q1 | -10.1 Million USD | 49.48% |
| 2023 Q3 | 39.45 Million USD | 290.8% |
| 2023 Q4 | 85.58 Million USD | 116.9% |
| 2022 Q2 | -24.81 Million USD | 0.0% |
| 2022 Q4 | -19.99 Million USD | -88.44% |
| 2022 FY | - USD | 22.01% |
| 2022 Q3 | -10.61 Million USD | 57.24% |
| 2021 Q2 | -18.98 Million USD | 0.0% |
| 2021 FY | - USD | -11.46% |
| 2021 Q4 | -39.3 Million USD | 0.0% |
| 2020 Q2 | -24.95 Million USD | 0.0% |
| 2020 FY | - USD | -2683.85% |
| 2020 Q4 | -25.77 Million USD | 0.0% |
| 2019 FY | - USD | 96.11% |
| 2019 Q4 | 14.64 Million USD | 0.0% |
| 2019 Q2 | -20.51 Million USD | 0.0% |
| 2018 FY | - USD | 0.07% |
| 2017 FY | - USD | -63.72% |
| 2016 FY | - USD | -34.62% |
| 2015 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 232.381% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 1686.095% |
| SQZ Biotechnologies Company | -64.14 Million USD | 246.612% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 641.382% |
| Mesoblast Limited | -62.38 Million USD | 250.727% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 6222.079% |
| Genus plc | 73.7 Million USD | -27.596% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 1522.338% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 2751.203% |
| Marizyme, Inc. | -34.28 Million USD | 374.312% |
| ContraFect Corporation | -64.99 Million USD | 244.676% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 1172.026% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 2177.642% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 6808.346% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 3656.059% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 4146.704% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 18252.466% |
| Accustem Sciences Inc. | -3.74 Million USD | 2610.08% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 294.991% |
| EV Biologics, Inc. | -1.26 Million USD | 7521.336% |
| Q BioMed Inc. | -617.62 Thousand USD | 15325.69% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | -2532.646% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 14969.898% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 4216.375% |
| Biomind Labs Inc. | -1.03 Million USD | 9189.77% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 9.87 Million USD | -852.092% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 1413.148% |
| Skye Bioscience, Inc. | -13.54 Million USD | 794.134% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 6422.265% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 376252.504% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 2520.968% |
| IMV Inc. | -35.52 Million USD | 364.722% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 692.563% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 3858.575% |
| GB Sciences, Inc. | -1.41 Million USD | 6722.94% |
| Alpha Cognition Inc. | -9.7 Million USD | 1068.906% |
| HST Global, Inc. | -5303.00 USD | 1773400.509% |
| CSL Limited | 4.78 Billion USD | 98.036% |
| Halberd Corporation | -74.27 Thousand USD | 126701.228% |
| Enzolytics Inc. | -2.12 Million USD | 4531.519% |
| Resverlogix Corp. | -11.74 Million USD | 900.87% |
| Affymax, Inc. | -14.29 Million USD | 757.839% |
| SYBLEU INC | -141.57 Thousand USD | 66524.71% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 3170.115% |
| argenx SE | -216.02 Million USD | 143.532% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 269.931% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | -7627.044% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 6373.784% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | -24722.388% |
| AVAX Technologies, Inc. | -6.11 Million USD | 1638.42% |
| Zenith Capital Corp. | -8.6 Million USD | 1192.704% |
| Genscript Biotech Corporation | -248.71 Million USD | 137.809% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 539897.52% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 3943.843% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 53523.359% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 337.249% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 3351.298% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 9087.58% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | -1398444.408% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 5473.61% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 4995.496% |
| BioStem Technologies, Inc. | -7.55 Million USD | 1344.937% |
| ONE Bio Corp. | 13.61 Million USD | -590.794% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 52029.518% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 4671.615% |
| Agentix Corp. | -1.37 Million USD | 6955.31% |
| LadRx Corporation | 412.28 Thousand USD | -22709.12% |
| Cell Source, Inc. | -4.27 Million USD | 2300.996% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 25708.047% |
| Regen BioPharma, Inc. | 1.46 Million USD | -6314.799% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 10136.632% |
| NovAccess Global Inc. | -1.03 Million USD | 9187.592% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | -962.122% |
| Itoco Inc. | -1.86 Million USD | 5131.481% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 24871.647% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 8526.355% |
| Kadimastem Ltd | -2.62 Million USD | 3683.25% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 39421.817% |
| CytoDyn Inc. | -18.02 Million USD | 621.594% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 119091.922% |
| Mobile Lads Corp. | -2.24 Million USD | 4295.96% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | 769076.417% |
| Qrons Inc. | -40.08 Thousand USD | 234720.209% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 19462.237% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | -17729.397% |
| Rebus Holdings, Inc. | -951 Thousand USD | 9988.341% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 8954.731% |
| International Stem Cell Corporation | 202 Thousand USD | -46453.528% |
| Bioxytran, Inc. | -3.82 Million USD | 2561.636% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 178743.856% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 3919.688% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 362.171% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -45 Thousand USD | 209073.613% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 3534.555% |
| Neutra Corp. | -181.24 Thousand USD | 51983.963% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 566.482% |
| PureTech Health plc | -11.62 Million USD | 908.791% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 566.514% |
| IXICO plc | -707 Thousand USD | 13401.008% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 1323.658% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 294.511% |
| CSL Limited | 4.73 Billion USD | 98.013% |
| Cellectis S.A. | -92.63 Million USD | 201.514% |